Telix Pharmaceuticals Submits New Drug Application to US FDA for Prostate Cancer Imaging Product

NEXT STORY
Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
PREV STORY
MediciNova Announces Positive Clinical Results Regarding MN-166 (ibudilast) for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and Pharmacology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TYME Launches Pivotal Stage of TYME-88-PANC Trial to Evaluate SM-88 for Third-Line Treatment of Patients with Metastatic Pancreatic Cancer

author_avatar
NASDAQ Market News

Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the American College of Gastroenterology 2021 Annual Scientific Meeting

author_avatar
NASDAQ Market News

Sanofi : Le New England Journal of Medicine publie des données montrant que Jevtana® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer de la prosta

author_avatar
NASDAQ Market News